Bayer’s subsidiary BlueRock Therapeutics’s trial will eventually enroll 10 participants. Patients will have dopamine-producing cells surgically implanted into a part of the brain called the putamen.
Bayer's Cell, Gene Therapies for Parkinso... - Cure Parkinson's
Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials
Written by
Farooqji
To view profiles and participate in discussions please or .
1 Reply
•
Study record for the iPSC trial:
Phase 1 Safety and Tolerability Study of MSK-DA01 Cell Therapy for Advanced Parkinson's Disease - Full Text View - ClinicalTrials.gov
clinicaltrials.gov/ct2/show...
Study record for the gene therapy trial:
GDNF Gene Therapy for Parkinson's Disease - Full Text View - ClinicalTrials.gov
clinicaltrials.gov/ct2/show...
Both trials are currently recruiting PwPs.
Not what you're looking for?
You may also like...
Monkeys Aren't Human and Animal \"Models\" of Parkinson's Disease Aren't Actually Parkinson's Disease, BUT This Stem Cell Trial Offers Hope!
way for trials in human patients.
https://www.the-scientist.com/sponsored-article/stem-cell-transpla
Propionic acid (sodium propionate) - Does anyone have any experience?
https://www.cell.com/cell/fulltext/S0092-8674(20)30212-9?_returnURL=https%3A%2F%2Flinkinghub.elsevie
BlueRock the first company to report initial success treating Parkinson's disease in humans using an experimental stem cell therapy
https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-phase-i-trial-results-parkinsons-c
Bayer reports positive early data for Parkinson’s cell therapy
Therapeutics subsidiary, appeared safe and well-tolerated in a 12-person clinical trial....
Stem Cell Therapy for Parkinsons
https://www.ucihealth.org/blog/2024/01/restoring-dopamine-in-parkinsons-patients
Very exiciting...
Related Posts
Clinical trial suggests Parkinson's drug is safe in humans
Potential disease-modifying therapy enters Phase 2- Parkinson's Disease:- \"Parkinson's and the B1 Therapy\" with Daphne Bryan
- Designer DNA drug therapy for Parkinson's disease trial initiation expected in 2023
\"First ever successful experimental stem cell therapy for Parkinson's Disease\"
